Davis Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Sell
4,600
-11
-0.2% -$3.77K 0.51% 34
2026
Q1
$1.62M Sell
4,611
-16
-0.3% -$5.7K 0.57% 30
2025
Q4
$1.52M Sell
4,627
-32
-0.7% -$10.2K 0.53% 33
2025
Q3
$1.39M Sell
4,659
-206
-4% -$59.7K 0.47% 37
2025
Q2
$1.41M Buy
4,865
+1,947
+67% +$552K 0.51% 34
2025
Q1
$858K Buy
+2,918
New +$862K 0.38% 46

Other funds holding AMGN

Davis Investment Partners's AMGN Position: Q2 2026 in Review

Davis Investment Partners reduced its Amgen (AMGN) stake by 0.24% in Q2 2026, selling an estimated $3.77K and leaving 4,600 shares worth $1.67M. The position accounts for 0.51% of the portfolio, ranked #34.

Davis Investment Partners first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Davis Investment Partners held 4,600 shares of Amgen worth $1.67M as of Q2 2026.
  • Davis Investment Partners sold 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.51% of Davis Investment Partners's portfolio in Q2 2026, its #34 holding.
  • Davis Investment Partners first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.